ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief; Jerome Green To Head NIH Div. Of Research Grants; M.D. Anderson’s Even Hersh To Join Univ. of Arizona

December 13, 1985

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected

October 1, 1976

Genentech’s Ferrara Selected for GM Award.

June 23, 2006